Schedule 13D ownership disclosure
Evofem Biosciences Operations, Inc.
Security class unavailable · CUSIP: 30048L104
Event date: 2021-03-25
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 9,849,545
- Percent of class
- 9.9000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000914208-21-000340
- Form type
- SC 13D
- Filer
- Evofem Biosciences, Inc.
- CIK
- CIK 1618835
- Filed
- Mar 31, 2021
- Reporting period
- Mar 25, 2021
- Description
- Schedule 13D beneficial ownership